Elite Pharmaceuticals, Inc. (ELTP)
USD 0.55
(-0.36%)
USD 0.55
(-0.36%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.28 Million | 3.33 Million | 6.5 Million | 3.19 Million | -1.79 Million | -6.79 Million |
| Net Income | 20.1 Million | 3.56 Million | 8.89 Million | 5.08 Million | -2.24 Million | -9.27 Million |
| Depreciation & Amortization | 1.53 Million | 1.34 Million | 1.43 Million | 1.52 Million | 1.51 Million | 1.25 Million |
| Deferred income taxes | -19.98 Million | 1.5 Billion | -2.17 Million | -2.29 Million | 1.11 Million | 448.92 Thousand |
| Stock-based compensation | 6.75 Million | 579.32 Thousand | 781.47 Thousand | 935.62 Thousand | 1.02 Million | 1.71 Million |
| Change in working capital | -11.88 Million | -2.02 Million | -1.01 Million | -2.05 Million | -3.2 Million | -942.15 Thousand |
| Other non-cash items | 22.2 Million | -1.5 Billion | -1.42 Million | 2186.00 | 2081.00 | 5254.00 |
| Investing Cash Flow | -809.65 Thousand | -5.73 Million | -498.56 Thousand | -262.78 Thousand | -34.95 Thousand | 330.87 Thousand |
| Investments in PPE | -809.65 Thousand | -5.73 Million | -498.56 Thousand | -329.98 Thousand | -34.95 Thousand | -19.13 Thousand |
| Acquisitions | - | - | - | 67.2 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 67.2 Thousand | - | 350 Thousand |
| Financing Cash Flow | 3.38 Million | 1.7 Million | -667.13 Thousand | -869.82 Thousand | 689.53 Thousand | 1.56 Million |
| Debt repayment | -3.33 Million | -12.73 Million | -667.13 Thousand | -1.92 Million | -748.44 Thousand | -496.68 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 159.92 Million | 39.32 Million | 14.35 Million | 42.22 Thousand | 1.43 Million | 2.09 Million |
| Other Financing Activities | 46.44 Thousand | -24.88 Million | -14.35 Million | 1.01 Million | 689.53 Thousand | -28.72 Thousand |
| Accounts receivables | -16.59 Million | -36.63 Thousand | 438.46 Thousand | 610.47 Thousand | -2.78 Million | -545.92 Thousand |
| Accounts payables | 7.78 Million | 1.33 Million | 314.21 Thousand | -1.76 Million | 344.39 Thousand | 61 Thousand |
| Inventory | -3.37 Million | -2.8 Million | -1.72 Million | -870.43 Thousand | 373.25 Thousand | 382.27 Thousand |
| Other working capital | 313.2 Thousand | -516.01 Thousand | -34.44 Thousand | -29.06 Thousand | -1.13 Million | -839.5 Thousand |
| Cash at beginning of period | 7.83 Million | 8.94 Million | 3.59 Million | 1.53 Million | 2.67 Million | 7.57 Million |
| Cash at end of period | 7.1 Million | 8.24 Million | 8.94 Million | 3.59 Million | 1.53 Million | 2.67 Million |
| Capital Expenditure | -809.65 Thousand | -5.73 Million | -498.56 Thousand | -329.98 Thousand | -34.95 Thousand | -19.13 Thousand |
| Effect of forex changes on cash | - | -695.01 Million | - | - | - | - |
| Net cash flow / Change in cash | -725.98 Thousand | -695.71 Thousand | 5.34 Million | 2.06 Million | -1.13 Million | -4.89 Million |
| Free Cash Flow | -4.09 Million | -2.39 Million | 6 Million | 2.86 Million | -1.82 Million | -6.81 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 20.1 Million | 3.32 Million | 706.35 Thousand | 14.93 Million | 1.14 Million | 3.56 Million |
| Depreciation & Amortization | 1.53 Million | 513.8 Thousand | 350.52 Thousand | 329.32 Thousand | 337.36 Thousand | 1.34 Million |
| Deferred income taxes | -19.98 Million | -1.92 Million | -800.43 Thousand | -14.86 Million | 4.51 Million | 1.5 Billion |
| Stock-based compensation | 8.51 Million | 7.84 Million | 612.92 Thousand | 42.77 Thousand | 15 Thousand | 579.32 Thousand |
| Change in working capital | -11.88 Million | 2.29 Million | -6.94 Million | -2.75 Million | -4.48 Million | -2.02 Million |
| Other non-cash items | 22.2 Million | -3.1 Million | 3.66 Million | 2.07 Million | -4.22 Million | -1.5 Billion |
| Investing Cash Flow | -809.65 Thousand | -403.64 Thousand | -406 Thousand | - | - | -5.73 Million |
| Investments in PPE | -809.65 Thousand | -403.64 Thousand | -406 Thousand | - | - | -5.73 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 3.38 Million | -361.44 Thousand | -17.9 Thousand | -179.49 Thousand | 3.95 Million | 1.7 Million |
| Debt repayment | -3.33 Million | -400.96 Thousand | -24.82 Thousand | -179.49 Thousand | -42.77 Thousand | -12.73 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 159.92 Million | 159.92 Million | - | - | - | 39.32 Million |
| Other Financing Activities | 46.44 Thousand | 39.52 Thousand | 6923.00 | -179.49 Thousand | 4 Million | -24.88 Million |
| Accounts receivables | -16.59 Million | -3.48 Million | -5.67 Million | -4.22 Million | -3.2 Million | -36.63 Thousand |
| Accounts payables | 7.78 Million | 4.07 Million | -1.5 Million | 4.89 Million | 309.55 Thousand | 1.33 Million |
| Inventory | -3.37 Million | 1.39 Million | 899.34 Thousand | -4.05 Million | -1.61 Million | -2.8 Million |
| Other working capital | 313.2 Thousand | 305.22 Thousand | -662.56 Thousand | 632.74 Thousand | 25.06 Thousand | -516.01 Thousand |
| Cash at beginning of period | 7.83 Million | 5.81 Million | 8.65 Million | 9.49 Million | 8.24 Million | 8.94 Million |
| Cash at end of period | 7.1 Million | 7.1 Million | 5.81 Million | 9.07 Million | 9.49 Million | 8.24 Million |
| Capital Expenditure | -809.65 Thousand | -403.64 Thousand | -406 Thousand | - | - | -5.73 Million |
| Effect of forex changes on cash | - | 5249.00 | -5249.00 | - | - | -695.01 Million |
| Net cash flow / Change in cash | -725.98 Thousand | 1.29 Million | -2.83 Million | -415.43 Thousand | 1.24 Million | -695.71 Thousand |
| Free Cash Flow | -4.09 Million | 1.65 Million | -2.81 Million | -235.93 Thousand | -2.7 Million | -2.39 Million |
DEEPAKNTR
5211
6859
UMESLTD
FGPHF
3701